Cybrexa Revenue, Growth & Competitor Profile

DBA CYBREXA THERAPEUTICS

Company Profile & Annual Report for Cybrexa

Access the complete profile.

Cybrexa Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	5416 Management, Scientific & Technical Consulting Services
Address	5 Science Park New Haven, CT 06511

Note: Revenues for privately held companies are statistical evaluations.


Cybrexa's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Cybrexa's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Cybrexa is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Cybrexa Annual Revenue and Growth Rate

Cybrexa	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Cybrexa's revenues are gauged from an analysis of company filings.

Cybrexa's Income Statement (based on Industry Averages)

Cybrexa P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Cybrexa has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
June 24, 2022	20	75%	$54 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Cybrexa is developing and marketing. Cybrexa doesn't have any recent trademark applications, indicating Cybrexa is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ALPHALEX Peptide based tumor targeting technology, namely, a synthetic peptide attached via a self immolating chemical linker to an active pharmaceutical drug that specifically delivers active pharmaceutical drugs into the tumor cells while sparing normal tissues utilizing the low pH conditions of the tumor micro environment	11/16/2018
CYBREXA THERAPEUTICS Pharmaceutical drug development services, namely, development of small molecule drugs for use in humans	03/29/2017
CYBREXA Pharmaceutical drug development services, namely, development of small molecule drugs for use in humans	01/26/2017

See all trademarks and details in the Full Report.

Market Share of Cybrexa's Largest Competitors

A competitive analysis shows these companies are in the same general field as Cybrexa, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Cybrexa. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BIOHAVEN PHARMACEUTICALS	New Haven, CT	100
ARVINAS	New Haven, CT	42
INVICRO	New Haven, CT	8
ACHILLION PHARMACEUTICALS	New Haven, CT	4
INSTITUTE FOR NEURODEGENERATIVE DISORDERS	New Haven, CT	3
ATLASXOMICS	New Haven, CT	2

Other Companies at 5 Science Park, New Haven CT

Company	Headquarters	Revenue ($ MM)
ARVINAS	New Haven, CT	100
CLIFFORD W. BEERS GUIDANCE CLINIC	New Haven, CT	23
ARTIFICIAL CELL TECHNOLOGIES	New Haven, CT	5
MID-FAIRFIELD CHILD GUIDANCE CENTER	New Haven, CT	5
VERINOMICS	New Haven, CT	3

Future Competition: Cybrexa's Fastest Growing Competitors

These companies are in the same general field as Cybrexa and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)